Citation: | XIE Jing, FAN Chunlin, XU Jie, ZHANG Jian, YE Wencai, ZHANG Xiaoqi. Alkaloids of Ervatamia pandacaqui[J]. Journal of China Pharmaceutical University, 2021, 52(3): 287-292. DOI: 10.11665/j.issn.1000-5048.20210304 |
[1] |
. Beijing:Science Press,1977:114.
|
[2] |
Li BT,Chen XM. Comparative reviewon apocynaceae in flora reipublicae popularis sinicae and flora of China[J]. Guihaia(广西植物),1997,17(4):299-305.
|
[3] |
Liu ZW,Yang TT,Wang WJ,et al. Ervahainine A,a new cyano-substituted oxindole alkaloid from Ervatamia hainanensis[J]. Tetrahedron Lett,2013,54(48):6498-6500.
|
[4] |
Tang BQ,Wang WJ,Huang XJ,et al. Iboga-type alkaloids from Ervatamia officinalis[J]. J Nat Prod,2014,77(8):1839-1846.
|
[5] |
Liu ZW,Huang XJ,Xiao HL,et al. New iboga-type alkaloids from Ervatamia hainanensis[J]. RSC Adv,2016,6(36):30277-30284.
|
[6] |
Liu ZW,Tang BQ,Zhang QH,et al. Ervaoffines E-G,three iboga-type alkaloids featuring ring C cleavage and rearrangement from Ervatamia officinalis[J]. RSC Adv,2017,7(35):21883-21889.
|
[7] |
Zhang QH,Ding Y,Bai WX,et al. Studies on alkaloids from Ervatamia pandacaqui[J]. China J Chin Mater Med(中国中药杂志),2018,43(7):1471-1475.
|
[8] |
Liu ZW,Zhang J,Li ST,et al. Ervadivamines A and B,two unusual trimeric monoterpenoid indole alkaloids from Ervatamia divaricata[J]. J Org Chem,2018,83(17):10613-10618.
|
[9] |
Kam TS,Loh KY,Wei C. Conophylline and conophyllidine:new dimeric alkaloids from Tabernaemontana divaricata[J]. J Nat Prod,1993,56(11):1865-1871.
|
[10] |
Kam TS,Pang HS,Choo YM,et al. Biologically active ibogan and vallesamine derivatives from Tabernaemontana divaricata[J]. Chem Biodivers,2004,1(4):646-656.
|
[11] |
Kam TS,Sim KM. Five new iboga alkaloids from Tabernaemontana corymbosa[J]. J Nat Prod,2002,65(5):669-672.
|
[12] |
Achenbach H,Benirschke M,Torrenegra R. Alkaloids and other compounds from seeds of Tabernaemontana cymosa[J]. Phytochemistry,1997,45(2):325-335.
|
[13] |
Clivio P,Richard B,Hadi HA,et al. Alkaloids from leaves and stem bark of Ervatamia polyneura[J]. Phytochemistry,1990,29(9):3007-3011.
|
[14] |
Kam TS,Yoganathan K,Mok SL. Aspidofractinine alkaloids from Kopsia teoi[J]. Phytochemistry,1997,46(4):789-792.
|
[15] |
He YL,Chen WM,Feng XZ. Studies on chemical constituents of Longzhou Shancheng(Melodinus morsei)[J]. Chin Tradit Herbal Drugs(中草药),1993,24(12):623-625,670.
|
[16] |
Azoug M,Loukaci A,Richard B,et al. Alkaloids from stem bark and leaves of Peschiera buchtieni[J]. Phytochemistry,1995,39(5):1223-1228.
|
[17] |
Luo XG,Chen HS,Liang S,et al. Alkaloids from stems of Ervatamia yunnanensis[J]. Chin Chem Lett,2007,18(6):697-699.
|
[1] | HOU Kai, LI Ping, ZHANG Jinlian, WANG Fang, YANG Yu. Blood coagulation factor XI: new strategy of targeted anticoagulant therapy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 708-714. DOI: 10.11665/j.issn.1000-5048.2023050101 |
[2] | YE Zhenning, WU Zhenghong, ZHANG Huaqing. Research progress of blood-brain barrier crossing strategies and brain-targeted drug delivery mediated by nano-delivery system[J]. Journal of China Pharmaceutical University, 2024, 55(5): 590-602. DOI: 10.11665/j.issn.1000-5048.2024052202 |
[3] | LIU Yanhong, CHEN Liqing, ZHANG Xintong, GAO Zhonghao, HUANG Wei. Research progress of tumor immunomodulation strategies based on nanodrug delivery system[J]. Journal of China Pharmaceutical University, 2023, 54(1): 5-14. DOI: 10.11665/j.issn.1000-5048.2023021501 |
[4] | WANG Yanmei, YANG Lei, XIN Xiaofei, YIN Lifang. Combination therapy and drug delivery strategies for treatment of non-alcoholic fatty liver disease[J]. Journal of China Pharmaceutical University, 2022, 53(4): 423-432. DOI: 10.11665/j.issn.1000-5048.20220405 |
[5] | ZHOU Xinyuan, LIU Nan, ZHANG Pan, HUO Meirong. Advances in research on therapeutic strategies of targeting pancreatic cancer stroma[J]. Journal of China Pharmaceutical University, 2021, 52(6): 653-662. DOI: 10.11665/j.issn.1000-5048.20210602 |
[6] | FENG Yang, XU Xiao, MO Ran. Advances in lymphatic targeted drug delivery system for treatment of tumor metastasis[J]. Journal of China Pharmaceutical University, 2020, 51(4): 425-432. DOI: 10.11665/j.issn.1000-5048.20200406 |
[7] | YANG Shan, XU Cheng, YAO Jing. Strategies of nano drug delivery system applied in anti-angiogenic therapy[J]. Journal of China Pharmaceutical University, 2019, 50(1): 11-18. DOI: 10.11665/j.issn.1000-5048.20190102 |
[8] | SONG Ke, PAN Hao, HAN Jiayi, CHEN Lijiang. Nano drug delivery system based strategies to target tumor microenvironment[J]. Journal of China Pharmaceutical University, 2018, 49(4): 392-400. DOI: 10.11665/j.issn.1000-5048.20180402 |
[9] | SU Zhigui, MO Ran, ZHANG Can. Advances of nano-drug delivery systems overcoming the physiological and pathological barriers of tumor[J]. Journal of China Pharmaceutical University, 2015, 46(1): 28-39. DOI: 10.11665/j.issn.1000-5048.20150103 |
[10] | KE Xue. Advances in targeted drug delivery system[J]. Journal of China Pharmaceutical University, 2012, 43(1): 9-15. |
1. |
翟允耀,章晓骅. 化学仿制药制剂开发中晶型研究思路探讨. 药品评价. 2024(02): 131-133 .
![]() | |
2. |
梁霖霖,王志伟,何小双,衡伟利,钱帅,高缘,张建军,魏元锋. 机械外力对中药提取物晶体学固态形式及溶出速率的影响研究——以女贞子提取物为例. 中国药科大学学报. 2024(06): 767-774 .
![]() |